Get started
Author

Yuhei Kinehara

Apoptosis-derived membrane vesicles drive the cGAS–STING pathway and enhance type I IFN production in systemic lupus erythematosus
2018 · Yasuhiro Kato, JeongHoon Park, et al. · Annals of the Rheumatic Diseases · 326
PDF
Clinical implications of monitoring nivolumab immunokinetics in non–small cell lung cancer patients
2018 · Akio Osa, Takeshi Uenami, et al. · JCI Insight · 232
PDF
Semaphorin 6D reverse signaling controls macrophage lipid metabolism and anti-inflammatory polarization
2018 · Sujin Kang, Yoshimitsu Nakanishi, et al. · Nature Immunology · 126
Eosinophil-derived neurotoxin enhances airway remodeling in eosinophilic chronic rhinosinusitis and correlates with disease severity
2018 · Takeshi Tsuda, Yohei Maeda, et al. · International Immunology · 74
PDF
Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitis
2017 · Masayuki Nishide, Satoshi Nojima, et al. · Annals of the Rheumatic Diseases · 68
PDF
Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cells
2018 · Yuhei Kinehara, Izumi Nagatomo, et al. · JCI Insight · 40
PDF
In Silico Evaluation of Particle Transport and Deposition in the Airways of Individual Patients with Chronic Obstructive Pulmonary Disease
2022 · Kazunori Kadota, Koichi Matsumoto, et al. · SSRN Electronic Journal · 37
LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activation
2016 · Keiko Morimoto, Yoshihiro Baba, et al. · Scientific Reports · 28
PDF
Lysosomal Protein Lamtor1 Controls Innate Immune Responses via Nuclear Translocation of Transcription Factor EB
2018 · Yoshitomo Hayama, Tetsuya Kimura, et al. · The Journal of Immunology · 27
IL-33 Induces Sema4A Expression in Dendritic Cells and Exerts Antitumor Immunity
2021 · Yasuhiko Suga, Izumi Nagatomo, et al. · The Journal of Immunology · 22
Lamtor1 Is Critically Required for CD4+ T Cell Proliferation and Regulatory T Cell Suppressive Function
2017 · Takashi Hosokawa, Tetsuya Kimura, et al. · The Journal of Immunology · 21
Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study
2024 · Kinnosuke Matsumoto, Takayuki Shiroyama, et al. · Cancer Immunology Immunotherapy · 20
PDF
SEMA4A promotes eosinophil survival and contributes to eosinophil-mediated allergic diseases
2018 · Yohei Maeda, Takeshi Tsuda, et al. · Allergology International · 19
PDF
Timing of first pembrolizumab infusion and long-term outcomes in non-small cell lung cancer: A retrospective multicenter study
2025 · Akihiro Tsukaguchi, Kinnosuke Matsumoto, et al. · European Journal of Cancer · 17
Dapsone Hypersensitivity Syndrome-related Lung Injury without Eosinophilia in the Bronchoalveolar Lavage Fluid
2015 · Yuhei Kinehara, Takashi Kijima, et al. · Internal Medicine · 16
PDF
Risk Stratification According to Baseline and Early Change in Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Treated with Chemoimmunotherapy: A Multicenter Real-World Study
2024 · Kinnosuke Matsumoto, Yuji Yamamoto, et al. · Targeted Oncology · 13
Neuropsychiatric Immune-related Adverse Events Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma and Systemic Lupus Erythematosus
2019 · Misato Jono, Yuhei Kinehara, et al. · Internal Medicine · 12
PDF
Development of microscopic polyangiitis-related pulmonary fibrosis in a patient with autoimmune pulmonary alveolar proteinosis
2014 · Yuhei Kinehara, Hiroshi Kida, et al. · BMC Pulmonary Medicine · 12
PDF
Inflammatory Thoracic Aortic Aneurysm in a Patient with Advanced Lung Adenocarcinoma Treated with Pembrolizumab
2022 · Ryusuke Ninomiya, Yuhei Kinehara, et al. · Internal Medicine · 10
PDF
Single-cell spatial analysis identifies ID1-high endothelial cells in tertiary lymphoid structures as predictors of durable response to immunotherapy in non-small cell lung cancer
2026 · Kinnosuke Matsumoto, Yoshimi Noda, et al. · Cancer Cell International · 9
Successful continuous nivolumab therapy for metastatic non‐small cell lung cancer after local treatment of oligometastatic lesions
2020 · Satoshi Tobita, Yuhei Kinehara, et al. · Thoracic Cancer · 9
PDF
Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in non-small cell lung cancer
2018 · Takuya Shintani, Kazuma Higashisaka, et al. · Oncotarget · 9
PDF
Trastuzumab emtansine suppresses the growth of HER2-positive small-cell lung cancer in preclinical models
2017 · Osamu Morimura, Toshiyuki Minami, et al. · Biochemical and Biophysical Research Communications · 9
Impact of Lymphopenia Recovery After Chemoradiotherapy on Durvalumab Consolidation Therapy in Stage III NSCLC
2023 · Tomoki Kuge, Takayuki Shiroyama, et al. · JTO Clinical and Research Reports · 8
Metastatic Lung Tumors from Colorectal Cancer with EGFR Mutations That Responded to Osimertinib
2022 · Atsushi Yanagisawa, Yuhei Kinehara, et al. · Internal Medicine · 7
PDF
Works count: 45
Citation count: 1,195
H-index: 15
I10-index: 19
Year
Topic
Type